Literature DB >> 10944116

dMi-2 and ISWI chromatin remodelling factors have distinct nucleosome binding and mobilization properties.

A Brehm1, G Längst, J Kehle, C R Clapier, A Imhof, A Eberharter, J Müller, P B Becker.   

Abstract

Mi-2 and ISWI, two members of the Snf2 superfamily of ATPases, reside in separate ATP-dependent chromatin remodelling complexes. These complexes differ in their biochemical properties and are believed to perform distinct functions in the cell. We have compared the remodelling activity of recombinant Drosophila Mi-2 (dMi-2) with that of recombinant ISWI. Both proteins are nucleosome-stimulated ATPases and promote nucleosome mobilization. However, dMi-2 and ISWI differ in their interaction with nucleosome core particles, in their substrate requirements and in the direction of nucleosome mobilization. We have used antibodies to immobilize a complex containing dMi-2 and the dRPD3 histone deacetylase from Drosophila embryo extracts. This complex shares the nucleosome-stimulated ATPase and nucleosome mobilization properties of recombinant dMi-2, demonstrating that these activities are maintained in a physiological context. Its functional properties distinguish dMi-2 from both SWI2/SNF2 and ISWI, defining a new family of ATP-dependent remodelling machines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944116      PMCID: PMC302042          DOI: 10.1093/emboj/19.16.4332

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  CHD1 interacts with SSRP1 and depends on both its chromodomain and its ATPase/helicase-like domain for proper association with chromatin.

Authors:  D E Kelley; D G Stokes; R P Perry
Journal:  Chromosoma       Date:  1999-04       Impact factor: 4.316

2.  ISWI is an ATP-dependent nucleosome remodeling factor.

Authors:  D F Corona; G Längst; C R Clapier; E J Bonte; S Ferrari; J W Tamkun; P B Becker
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

Review 3.  Histone acetylases and deacetylases in cell proliferation.

Authors:  T Kouzarides
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

4.  Stable remodeling of tailless nucleosomes by the human SWI-SNF complex.

Authors:  J R Guyon; G J Narlikar; S Sif; R E Kingston
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

6.  The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth.

Authors:  A Brehm; S J Nielsen; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

7.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.

Authors:  Y Xue; J Wong; G T Moreno; M K Young; J Côté; W Wang
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

8.  ATP-dependent histone octamer sliding mediated by the chromatin remodeling complex NURF.

Authors:  A Hamiche; R Sandaltzopoulos; D A Gdula; C Wu
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

9.  Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.

Authors:  M L Phelan; S Sif; G J Narlikar; R E Kingston
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

10.  Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas.

Authors:  Y Toh; H Kuwano; M Mori; G L Nicolson; K Sugimachi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  86 in total

1.  Critical role for the histone H4 N terminus in nucleosome remodeling by ISWI.

Authors:  C R Clapier; G Längst; D F Corona; P B Becker; K P Nightingale
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  In vivo chromatin remodeling by yeast ISWI homologs Isw1p and Isw2p.

Authors:  N A Kent; N Karabetsou; P K Politis; J Mellor
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

3.  A critical epitope for substrate recognition by the nucleosome remodeling ATPase ISWI.

Authors:  Cedric R Clapier; Karl P Nightingale; Peter B Becker
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

4.  Acf1, the largest subunit of CHRAC, regulates ISWI-induced nucleosome remodelling.

Authors:  A Eberharter; S Ferrari; G Längst; T Straub; A Imhof; P Varga-Weisz; M Wilm; P B Becker
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

5.  Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor.

Authors:  H B Wang; Y Zhang
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

6.  Identification and functional characterization of the p66/p68 components of the MeCP1 complex.

Authors:  Qin Feng; Ru Cao; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Yi Zhang
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Evidence for DNA translocation by the ISWI chromatin-remodeling enzyme.

Authors:  Iestyn Whitehouse; Chris Stockdale; Andrew Flaus; Mark D Szczelkun; Tom Owen-Hughes
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

8.  Dynamic properties of nucleosomes during thermal and ATP-driven mobilization.

Authors:  Andrew Flaus; Tom Owen-Hughes
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  Identification and analysis of chromodomain-containing proteins encoded in the mouse transcriptome.

Authors:  Khairina Tajul-Arifin; Rohan Teasdale; Timothy Ravasi; David A Hume; John S Mattick
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

Review 10.  Nucleosome sliding: facts and fiction.

Authors:  Peter B Becker
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.